Patents by Inventor Joao Luiz Sampaio Queiroz

Joao Luiz Sampaio Queiroz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies against the PBP2-A protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the phylum
    Patent number: 8940304
    Abstract: The present invention relates to monoclonal antibodies capable of recognizing and binding to the PBP2-a protein and to other proteins having sequences homologous to PBP2-a, including pathogenic species such as the methyciline-resistant Staphylococcus Aureus (MRSA), coagulase-negative Staphilococcus, Staphylococcus sciuri and Enterococcus, and any other bacteria containing the PBP2-a protein or homologous sequences. The invention also relates to the use of the monoclonal antibodies capable of recognizing and binding to the PBP2-a protein and to other proteins having sequences homologous to PBP2-a in a complementary immunodiagnostic test for detecting resistance to beta-lactam antibiotics.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: January 27, 2015
    Assignee: Fundaco Oswaldo Cruz
    Inventors: Jose Procopio Moreno Senna, Joao Luiz Sampaio Queiroz, Nadia Maria Batoreu, Maria da Gloria Martins Teixeira
  • MONOCLONAL ANTIBODIES AGAINST THE PBP2-A PROTEIN AND HOMOLOGOUS SEQUENCES FOR THE TREATMENT OF INFECTIONS BY AND IMMUNODIAGNOSTICS OF BACTERIA OF THE FIRMICUTES PHYLUM
    Publication number: 20120195907
    Abstract: The present invention relates to monoclonal antibodies capable of recognising and binding to the PBP2-a protein and to other proteins having sequences homologous to PBP2-a, including pathogenic species such as the methyciline-resistant Staphylococcus Aureus (MRSA), coagulase-negative Staphilococcus, Staphylococcus sciuri and Enterococcus, and any other bacteria containing the PBP2-a protein or homologous sequences. The invention also relates to the use of the monoclonal antibodies capable of recognising and binding to the PBP2-a protein and to other proteins having sequences homologous to PBP2-a in a complementary immunodiagnostic test for detecting resistance to beta-lactam antibiotics.
    Type: Application
    Filed: August 10, 2010
    Publication date: August 2, 2012
    Applicant: FUNDACAO OSWALDO CRUZ
    Inventors: Jose Procopio Moreno Senna, Joao Luiz Sampaio Queiroz, Nadia Maria Batoreu, Maria da Gloria Martins Teixeira